CORE--IMMUNOCYTOPATHOLOGY

$349,258P30FY2000MHNIH

University Of California San Francisco, San Francisco CA

Investigators

Linked publications & trials

Paper 24277811 Paper 22536001 Paper 22300770 Paper 21881481 Paper 21701594 Paper 21502083 Paper 21305005 Paper 21245154 Paper 21200021 Paper 20697404 Paper 20651585 Paper 20565257 Paper 20543654 Paper 20484731 Paper 20300008 Paper 20299968 Paper 20190142 Paper 20168202 Paper 20126452 Paper 19684507 Paper 19390417 Paper 19265479 Paper 19193107 Paper 19136668 Paper 19019971 Paper 18945778 Paper 18832873 Paper 18645515 Paper 18494556 Paper 18453567 Paper 18447613 Paper 18292808 Paper 18171295 Paper 17892849 Paper 17875580 Paper 17707394 Paper 17670829 Paper 17531001 Paper 17514014 Paper 17457090 Paper 17450501 Paper 17209769 Paper 17205477 Paper 17117013 Paper 17051502 Paper 16960780 Paper 16759047 Paper 16731954 Paper 16514299 Paper 16511415 Paper 16406047 Paper 16254352 Paper 16206068 Paper 16135789 Paper 16111893 Paper 15627028 Paper 15577628 Paper 15538390 Paper 15353986 Paper 15308569 Paper 15280779 Paper 15272393 Paper 15265956 Paper 15238769 Paper 15216458 Paper 15171256 Paper 15117761 Paper 15096800 Paper 15090769 Paper 15075514 Paper 15073672 Paper 15018666 Paper 14982739 Paper 14722897 Paper 14722292 Paper 14718321 Paper 14683662 Paper 14659906 Paper 14607901 Paper 13678542 Paper 12965981 Paper 12960825 Paper 12960823 Paper 12920522 Paper 12902815 Paper 12819521 Paper 12805458 Paper 12767994 Paper 12699013 Paper 12660541 Paper 12556690 Paper 12525647 Paper 12489286 Paper 12477812 Paper 12456660 Paper 12429519 Paper 12394795 Paper 12379072 Paper 12368352 Paper 12368346

Abstract

The goal of the Immunocytopathology Core is primarily one of providing access to surgical pathology specimens as well as providing molecular support. Specific services include: 1. Procurement and Delivery 2. Immunophenotyping 3. In situ hybridization 4. Histochemical special strains 5. In situ PCR The Director of the Core will additionally work with individual CFAR investigators to provide possible strategies for improving our ability to answer a number of important questions relating to HIV.

View original record on NIH RePORTER →